期刊文献+

Management of hypoxemia in SARS-CoV-2 infection:Lessons learned from one year of experience,with a special focus on silent hypoxemia

原文传递
导出
摘要 Silent hypoxemia is common in patients with severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)in-fection.In this article,the possible pathophysiological mechanisms underlying respiratory symptoms have been reviewed,and the presence of hypoxemia without hypoxia is also discussed.The experience we have gained since the start of the Coronavirus disease 19(COVID-19)pandemic has changed our point of view about which patients with respiratory involvement should be admitted to the intensive care unit/high-dependency unit for mechan-ical ventilation and monitoring.In patients with clinically well-tolerated mild to moderate hypoxemia(silent hypoxemia),regardless of the extent of pulmonary opacities found in radiological studies,the administration of supplemental oxygen therapy may increase the risk of endothelial damage.The risk of sudden respiratory arrest during emergency intubation,which could expose healthcare workers to infection,should be considered along with the risks of premature intubation.Criteria for intubation need to be revisited based on updated evidence showing that many patients with severe hypoxemia do not show increased work of breathing.This has implica-tions in patient management and may explain in part reports of broad differences in outcomes among intubated patients.
出处 《Journal of Intensive Medicine》 2021年第1期26-30,共5页 重症医学(英文)
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部